Intralesional Measles, Mumps, Rubella (MMR) Vaccine Versus Cryotherapy in Treatment of Multiple Common and Planter Warts

PHASE4CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

March 1, 2018

Study Completion Date

May 1, 2018

Conditions
Common WartPlantar Wart
Interventions
DRUG

Measles-Mumps-Rubella Vaccine

"MMR vaccine will be injected 0.5 ml into the largest wart at 2-week intervals until complete clearance was achieved or for a maximum of 3 treatments.~Response to treatment will be evaluated 1 month after the last session by decrease in the size of warts, decrease in the number of warts and photographic comparison. The clinical response was graded into complete (complete cure), partial (if there was a decrease in the size and\\or a decrease in the total number of warts), and no response (no change in size and number of warts)."

PROCEDURE

cryotherapy

"patients received cryotherapy with liquid nitrogen once every 2 weeks until complete clearance or for a maximum of 3 sessions.Response to treatment will be evaluated 1 month after the last session by decrease in the size of warts, decrease in the number of warts and photographic comparison.~The clinical response was graded into complete (complete cure), partial (if there was a decrease in the size and\\or a decrease in the total number of warts), and no response (no change in size and number of warts)."

Trial Locations (1)

71515

Assiut university hospitals, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03183765 - Intralesional Measles, Mumps, Rubella (MMR) Vaccine Versus Cryotherapy in Treatment of Multiple Common and Planter Warts | Biotech Hunter | Biotech Hunter